Drug Profile


Alternative Names: B 9004070; BY 4070

Latest Information Update: 20 May 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ALTANA Pharma
  • Class Antiallergics; Antiasthmatics; Bronchodilators; Naphthyridines
  • Mechanism of Action Phosphoric diester hydrolase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 20 May 1996 Discontinued-II for Asthma in Germany (Unknown route)
  • 10 May 1995 BY 4070 is now called tolafentrine
  • 10 May 1995 An in vitro study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top